2201 - 2250 of 8571 Results
Title
Year
-
RESTRICTEDTitle: Initial cognitive changes in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 4Start Page: 511End Page: 519Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27330Best OA location URL: https://europepmc.org/articles/pmc5920539?pdf=renderCitation Count: 44
- Targeting the pedunculopontine nucleus in Parkinson's disease: Time to go back to the drawing board2018RESTRICTEDTitle: Targeting the pedunculopontine nucleus in Parkinson's disease: Time to go back to the drawing boardJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 12Start Page: 1871End Page: 1875Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27540Best OA location URL: http://deepblue.lib.umich.edu/bitstream/2027.42/147041/2/mds27540_am.pdfCitation Count: 19
-
RESTRICTEDTitle: Gene Therapy Strategies to Restore ER Proteostasis in DiseaseJournal Name: Molecular TherapyPublisher: Elsevier BVVol: 26Issue #: 6Start Page: 1404End Page: 1413Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.ymthe.2018.04.004Best OA location URL: https://doi.org/10.1016/j.ymthe.2018.04.004Citation Count: 35
-
RESTRICTEDTitle: Parkinson's Disease Biomarkers: Where Are We and Where Do We Go Next?Journal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 4Issue #: 6Start Page: 796End Page: 805Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12545Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12545Citation Count: 18
-
RESTRICTEDTitle: Diagnosis and treatment of orthostatic hypotensionJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 21Issue #: 8Start Page: 735End Page: 746Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(22)00169-7Best OA location URL: https://pure.rug.nl/ws/files/234637992/1_s2.0_S1474442222001697_main.pdfCitation Count: 54
- Ansätze zur Etablierung von Präzisionsmedizin bei der Parkinson-Krankheit mit dem Schwerpunkt Genetik2020RESTRICTEDTitle: Ansätze zur Etablierung von Präzisionsmedizin bei der Parkinson-Krankheit mit dem Schwerpunkt GenetikJournal Name: Fortschritte der Neurologie · PsychiatriePublisher: Georg Thieme Verlag KGVol: 88Issue #: 09Start Page: 558End Page: 566Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1055/a-1149-2204Best OA location URL: http://www.thieme-connect.de/products/ejournals/pdf/10.1055/a-1149-2204.pdfCitation Count: 0
-
RESTRICTEDTitle: The economic imperatives for technology enabled wellness centered healthcareJournal Name: Journal of Public Health PolicyPublisher: Springer Science and Business Media LLCVol: 43Issue #: 3Start Page: 456End Page: 468Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1057/s41271-022-00356-8Best OA location URL: https://link.springer.com/content/pdf/10.1057/s41271-022-00356-8.pdfCitation Count: 2
- Alzheimer’s disease large-scale gene expression portrait identifies exercise as the top theoretical treatment2022RESTRICTEDTitle: Alzheimer’s disease large-scale gene expression portrait identifies exercise as the top theoretical treatmentJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-022-22179-zBest OA location URL: https://www.nature.com/articles/s41598-022-22179-z.pdfCitation Count: 17
- Sex and Race Reporting and Representation in Noncancerous Voice Clinical Trials: A Meta-Analysis of National Institutes of Health–Registered Research Between 1988 and 20212022RESTRICTEDTitle: Sex and Race Reporting and Representation in Noncancerous Voice Clinical Trials: A Meta-Analysis of National Institutes of Health–Registered Research Between 1988 and 2021Journal Name: Journal of Speech, Language, and Hearing ResearchPublisher: American Speech Language Hearing AssociationVol: 65Issue #: 7Start Page: 2594End Page: 2607Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1044/2022_jslhr-22-00141Citation Count: 6
-
RESTRICTEDTitle: Prodromal Parkinson disease — time is brainJournal Name: Nature Reviews NeurologyPublisher: Springer Science and Business Media LLCVol: 17Issue #: 6Start Page: 329End Page: 330Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/s41582-021-00489-6Citation Count: 1
-
OPENTitle: Elucidating the importance and regulation of key enhancers for human MEIS1 expressionJournal Name: LeukemiaPublisher: Springer Science and Business Media LLCVol: 36Issue #: 8Start Page: 1980End Page: 1989Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41375-022-01602-4Best OA location URL: https://www.nature.com/articles/s41375-022-01602-4.pdfCitation Count: 3
-
RESTRICTEDTitle: From the prodromal stage of multiple sclerosis to disease preventionJournal Name: Nature Reviews NeurologyPublisher: Springer Science and Business Media LLCVol: 18Issue #: 9Start Page: 559End Page: 572Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/s41582-022-00686-xCitation Count: 24
-
RESTRICTEDTitle: The potential utility of smell testing to screen for neurodegenerative disordersJournal Name: Expert Review of Molecular DiagnosticsPublisher: Informa UK LimitedVol: 22Issue #: 2Start Page: 139End Page: 148Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1080/14737159.2022.2037424Best OA location URL: https://qmro.qmul.ac.uk/xmlui/handle/123456789/76598Citation Count: 1
-
RESTRICTEDTitle: Practical pearls to improve the efficacy and tolerability of levodopa in Parkinson’s diseaseJournal Name: Expert Review of NeurotherapeuticsPublisher: Informa UK LimitedVol: 22Issue #: 6Start Page: 489End Page: 498Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1080/14737175.2022.2091436Citation Count: 4
-
RESTRICTEDTitle: Investigational therapeutics for the treatment of progressive supranuclear palsyJournal Name: Expert Opinion on Investigational DrugsPublisher: Informa UK LimitedVol: 31Issue #: 8Start Page: 813End Page: 823Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1080/13543784.2022.2087179Citation Count: 1
-
RESTRICTEDTitle: Can noninvasive brain stimulation enhance cognition in neuropsychiatric disorders?Journal Name: NeuropharmacologyPublisher: Elsevier BVVol: 64Issue #:Start Page: 566End Page: 578Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2012.06.020Best OA location URL: https://europepmc.org/articles/pmc3725288?pdf=renderCitation Count: 206
-
RESTRICTEDTitle: Pharmacological interventions for psychosis in Parkinson’s disease patientsJournal Name: Expert Opinion on PharmacotherapyPublisher: Informa UK LimitedVol: 19Issue #: 5Start Page: 499End Page: 505Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1080/14656566.2018.1445721Citation Count: 27
-
RESTRICTEDTitle: The Endo-lysosomal System in Parkinson’s Disease: Expanding the HorizonJournal Name: Journal of Molecular BiologyPublisher: Elsevier BVVol: 435Issue #: 12Start Page: 168140End Page: 168140Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jmb.2023.168140Best OA location URL: https://doi.org/10.1016/j.jmb.2023.168140Citation Count: 9
-
RESTRICTEDTitle: Gene therapy to target ER stress in brain diseasesJournal Name: Brain ResearchPublisher: Elsevier BVVol: 1648Issue #:Start Page: 561End Page: 570Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.brainres.2016.04.064Citation Count: 31
- Correction to Conversion of Quinazoline Modulators from Inhibitors to Activators of β-Glucocerebrosidase2019RESTRICTEDTitle: Correction to Conversion of Quinazoline Modulators from Inhibitors to Activators of β-GlucocerebrosidaseJournal Name: Journal of Medicinal ChemistryPublisher: American Chemical Society (ACS)Vol: 62Issue #: 5Start Page: 2850End Page: 2850Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acs.jmedchem.9b00284Best OA location URL: https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.9b00284Citation Count: 0
-
RESTRICTEDTitle: Enduring questions in regenerative biology and the search for answersJournal Name: Communications BiologyPublisher: Springer Science and Business Media LLCVol: 6Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1038/s42003-023-05505-7Best OA location URL: https://www.nature.com/articles/s42003-023-05505-7.pdfCitation Count: 0
-
OPENTitle: Genomics transformer for diagnosing Parkinson's diseaseJournal Name: 2022 IEEE-EMBS International Conference on Biomedical and Health Informatics (BHI)Publisher: IEEEVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1109/bhi56158.2022.9926815Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9942707Citation Count: 1
- Inflammatory Diseases Among Norwegian LRRK2 Mutation Carriers. A 15-Years Follow-Up of a Cohort2021RESTRICTEDTitle: Inflammatory Diseases Among Norwegian LRRK2 Mutation Carriers. A 15-Years Follow-Up of a CohortJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 15Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2021.634666Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2021.634666/pdfCitation Count: 3
- ACU193: An Immunotherapeutic Poised to Test the Amyloid β Oligomer Hypothesis of Alzheimer’s Disease2022RESTRICTEDTitle: ACU193: An Immunotherapeutic Poised to Test the Amyloid β Oligomer Hypothesis of Alzheimer’s DiseaseJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 16Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2022.848215Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2022.848215/pdfCitation Count: 17
-
RESTRICTEDTitle: Active Learning in Psychiatry Education: Current Practices and Future PerspectivesJournal Name: Frontiers in PsychiatryPublisher: Frontiers Media SAVol: 11Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fpsyt.2020.00211Best OA location URL: https://www.frontiersin.org/articles/10.3389/fpsyt.2020.00211/pdfCitation Count: 19
-
RESTRICTEDTitle: Drug Repurposing for Parkinson’s Disease: The International Linked Clinical Trials experienceJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 15Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2021.653377Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2021.653377/pdfCitation Count: 19
- Immunological Features of LRRK2 Function and Its Role in the Gut-Brain Axis Governing Parkinson’s Disease2023RESTRICTEDTitle: Immunological Features of LRRK2 Function and Its Role in the Gut-Brain Axis Governing Parkinson’s DiseaseJournal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 13Issue #: 3Start Page: 279End Page: 296Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-230021Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd230021?id=journal-of-parkinsons-disease%2Fjpd230021Citation Count: 3
- Transient Receptor Potential Channels as an Emerging Target for the Treatment of Parkinson’s Disease: An Insight Into Role of Pharmacological Interventions2020RESTRICTEDTitle: Transient Receptor Potential Channels as an Emerging Target for the Treatment of Parkinson’s Disease: An Insight Into Role of Pharmacological InterventionsJournal Name: Frontiers in Cell and Developmental BiologyPublisher: Frontiers Media SAVol: 8Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fcell.2020.584513Best OA location URL: https://www.frontiersin.org/articles/10.3389/fcell.2020.584513/pdfCitation Count: 28
- Therapeutic modulation of gene expression in the disease state: Treatment strategies and approaches for the development of next-generation of the epigenetic drugs2022RESTRICTEDTitle: Therapeutic modulation of gene expression in the disease state: Treatment strategies and approaches for the development of next-generation of the epigenetic drugsJournal Name: Frontiers in Bioengineering and BiotechnologyPublisher: Frontiers Media SAVol: 10Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fbioe.2022.1035543Best OA location URL: https://www.frontiersin.org/articles/10.3389/fbioe.2022.1035543/pdfCitation Count: 7
- Machine Learning Methods to Predict Acute Respiratory Failure and Acute Respiratory Distress Syndrome2020RESTRICTEDTitle: Machine Learning Methods to Predict Acute Respiratory Failure and Acute Respiratory Distress SyndromeJournal Name: Frontiers in Big DataPublisher: Frontiers Media SAVol: 3Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fdata.2020.579774Best OA location URL: https://www.frontiersin.org/articles/10.3389/fdata.2020.579774/pdfCitation Count: 16
- The Role of Parkinson Nurses for Personalizing Care in Parkinson’s Disease: A Systematic Review and Meta-Analysis2022RESTRICTEDTitle: The Role of Parkinson Nurses for Personalizing Care in Parkinson’s Disease: A Systematic Review and Meta-AnalysisJournal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 12Issue #: 6Start Page: 1807End Page: 1831Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-223215Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd223215?id=journal-of-parkinsons-disease%2Fjpd223215Citation Count: 4
- Genetics in parkinson’s disease: From better disease understanding to machine learning based precision medicine2022RESTRICTEDTitle: Genetics in parkinson’s disease: From better disease understanding to machine learning based precision medicineJournal Name: Frontiers in Molecular MedicinePublisher: Frontiers Media SAVol: 2Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fmmed.2022.933383Best OA location URL: https://www.frontiersin.org/articles/10.3389/fmmed.2022.933383/pdfCitation Count: 0
-
RESTRICTEDTitle: Annexins Bridging the Gap: Novel Roles in Membrane Contact Site FormationJournal Name: Frontiers in Cell and Developmental BiologyPublisher: Frontiers Media SAVol: 9Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fcell.2021.797949Best OA location URL: https://www.frontiersin.org/articles/10.3389/fcell.2021.797949/pdfCitation Count: 10
-
RESTRICTEDTitle: Epidemiological Evidence for an Immune Component of Parkinson’s DiseaseJournal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 12Issue #: s1Start Page: S29End Page: S43Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-223180Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd223180?id=journal-of-parkinsons-disease%2Fjpd223180Citation Count: 8
-
RESTRICTEDTitle: A Critical Analysis of Intestinal Enteric Neuron Loss and Constipation in Parkinson’s DiseaseJournal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 12Issue #: 6Start Page: 1841End Page: 1861Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3233/jpd-223262Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd223262?id=journal-of-parkinsons-disease%2Fjpd223262Citation Count: 8
-
RESTRICTEDTitle: Early-Onset Parkinson’s Disease: Creating the Right Environment for a Genetic DisorderJournal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 12Issue #: 8Start Page: 2353End Page: 2367Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-223380Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd223380?id=journal-of-parkinsons-disease%2Fjpd223380Citation Count: 6
- Neuroinflammation and Immune Changes in Prodromal Parkinson’s Disease and Other Synucleinopathies2022RESTRICTEDTitle: Neuroinflammation and Immune Changes in Prodromal Parkinson’s Disease and Other SynucleinopathiesJournal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 12Issue #: s1Start Page: S149End Page: S163Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-223245Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd223245?id=journal-of-parkinsons-disease%2Fjpd223245Citation Count: 23
- Effects of Levodopa-Carbidopa Intestinal Gel on Dyskinesia and Non-Motor Symptoms Including Sleep: Results from a Meta-Analysis with 24-Month Follow-Up2022RESTRICTEDTitle: Effects of Levodopa-Carbidopa Intestinal Gel on Dyskinesia and Non-Motor Symptoms Including Sleep: Results from a Meta-Analysis with 24-Month Follow-UpJournal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 12Issue #: 7Start Page: 2071End Page: 2083Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3233/jpd-223295Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd223295?id=journal-of-parkinsons-disease%2Fjpd223295Citation Count: 9
-
RESTRICTEDTitle: A Guide for the Differential Diagnosis of Multiple System Atrophy in Clinical PracticeJournal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 12Issue #: 7Start Page: 2015End Page: 2027Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-223392Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd223392?id=journal-of-parkinsons-disease%2Fjpd223392Citation Count: 5
- A Combined α-Synuclein/Fibril (SynFib) Model of Parkinson-Like Synucleinopathy Targeting the Nigrostriatal Dopamine System2022RESTRICTEDTitle: A Combined α-Synuclein/Fibril (SynFib) Model of Parkinson-Like Synucleinopathy Targeting the Nigrostriatal Dopamine SystemJournal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 12Issue #: 8Start Page: 2307End Page: 2320Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3233/jpd-223452Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd223452?id=journal-of-parkinsons-disease%2Fjpd223452Citation Count: 5
-
RESTRICTEDTitle: Infusion Therapies for Parkinson’s DiseaseJournal Name: Current Neurology and Neuroscience ReportsPublisher: Springer Science and Business Media LLCVol: 20Issue #: 9Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s11910-020-01062-2Citation Count: 12
-
RESTRICTEDTitle: The Role of Genetic Testing for Parkinson’s DiseaseJournal Name: Current Neurology and Neuroscience ReportsPublisher: Springer Science and Business Media LLCVol: 21Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s11910-021-01100-7Citation Count: 14
- Molecular Imaging of the Cholinergic System in Alzheimer and Lewy Body Dementias: Expanding Views2021RESTRICTEDTitle: Molecular Imaging of the Cholinergic System in Alzheimer and Lewy Body Dementias: Expanding ViewsJournal Name: Current Neurology and Neuroscience ReportsPublisher: Springer Science and Business Media LLCVol: 21Issue #: 10Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s11910-021-01140-zBest OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9020458Citation Count: 13
- Moving the Dial Toward Equity in Parkinson’s Disease Clinical Research: a Review of Current Literature and Future Directions in Diversifying PD Clinical Trial Participation2022RESTRICTEDTitle: Moving the Dial Toward Equity in Parkinson’s Disease Clinical Research: a Review of Current Literature and Future Directions in Diversifying PD Clinical Trial ParticipationJournal Name: Current Neurology and Neuroscience ReportsPublisher: Springer Science and Business Media LLCVol: 22Issue #: 8Start Page: 475End Page: 483Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s11910-022-01212-8Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9578442Citation Count: 12
- Management Strategies for Comorbid Supine Hypertension in Patients with Neurogenic Orthostatic Hypotension2021RESTRICTEDTitle: Management Strategies for Comorbid Supine Hypertension in Patients with Neurogenic Orthostatic HypotensionJournal Name: Current Neurology and Neuroscience ReportsPublisher: Springer Science and Business Media LLCVol: 21Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1007/s11910-021-01104-3Best OA location URL: https://link.springer.com/content/pdf/10.1007/s11910-021-01104-3.pdfCitation Count: 6
-
RESTRICTEDTitle: Neurodegeneration and Neuroinflammation in Parkinson’s Disease: a Self-Sustained LoopJournal Name: Current Neurology and Neuroscience ReportsPublisher: Springer Science and Business Media LLCVol: 22Issue #: 8Start Page: 427End Page: 440Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1007/s11910-022-01207-5Best OA location URL: https://link.springer.com/content/pdf/10.1007/s11910-022-01207-5.pdfCitation Count: 23
- Complementary Therapies in Parkinson Disease: a Review of Acupuncture, Tai Chi, Qi Gong, Yoga, and Cannabis2020RESTRICTEDTitle: Complementary Therapies in Parkinson Disease: a Review of Acupuncture, Tai Chi, Qi Gong, Yoga, and CannabisJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 17Issue #: 4Start Page: 1434End Page: 1455Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s13311-020-00900-yBest OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-020-00900-y.pdfCitation Count: 49
-
RESTRICTEDTitle: Management of Tardive Syndrome: Medications and Surgical TreatmentsJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 17Issue #: 4Start Page: 1694End Page: 1712Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s13311-020-00898-3Best OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-020-00898-3.pdfCitation Count: 15
- Approaches to Disease Modification for Parkinson’s Disease: Clinical Trials and Lessons Learned2020RESTRICTEDTitle: Approaches to Disease Modification for Parkinson’s Disease: Clinical Trials and Lessons LearnedJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 17Issue #: 4Start Page: 1393End Page: 1405Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s13311-020-00964-wBest OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-020-00964-w.pdfCitation Count: 20
-
RESTRICTEDTitle: Symptomatic Care in Multiple System Atrophy: State of the ArtJournal Name: The CerebellumPublisher: Springer Science and Business Media LLCVol: 22Issue #: 3Start Page: 433End Page: 446Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1007/s12311-022-01411-6Best OA location URL: https://link.springer.com/content/pdf/10.1007/s12311-022-01411-6.pdfCitation Count: 7